fbpx

Primary Biliary Cholangitis (Primary Biliary Cirrhosis)

Updated : September 16, 2022





Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

 

obeticholic acid 

Initially, 5 mg orally each day
Maintenance dose- 5 mg orally each day
If no reduction is seen in alkaline phosphatase or total bilirubin after 3 months, increase the dose to 10 mg orally each day
Maximum dose-10 mg each day



taurursodiol 

The recommended daily dose based on body weight is 10mg/kg



 
 

Media Gallary

References

Primary Biliary Cholangitis (Primary Biliary Cirrhosis)

Updated : September 16, 2022




obeticholic acid 

Initially, 5 mg orally each day
Maintenance dose- 5 mg orally each day
If no reduction is seen in alkaline phosphatase or total bilirubin after 3 months, increase the dose to 10 mg orally each day
Maximum dose-10 mg each day



taurursodiol 

The recommended daily dose based on body weight is 10mg/kg